Literature DB >> 31028487

Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction.

Fiorenza De Rose1, Antonella Fogliata2, Davide Franceschini1, Salvatore Cozzi1, Cristina Iftode1, Antonella Stravato1, Stefano Tomatis1, Giovanna Masci3, Rosalba Torrisi3, Alberto Testori4, Corrado Tinterri4, Andrea V E Lisa5, Luca Maione5, Valeriano Vinci5, Marco Klinger5, Armando Santoro3,6, Marta Scorsetti1,6.   

Abstract

Postmastectomy radiotherapy (PMRT) following immediate breast reconstruction is increasingly adopted in the management of breast cancer patients. We retrospectively evaluate the complication rates of PMRT using VMAT technique to immediate tissue expander-based reconstructions and the possible impact of tissue expander volume on radiotherapy planning. We reviewed the data of patients who underwent immediate expander breast reconstruction and received PMRT with VMAT (50 Gy in 25 fractions) on the reconstructed breast and axillary levels III-IV. Neoadjuvant or adjuvant systemic therapy was administered in most of the patients. Autologous fat grafting was routinely performed at the time of second-stage reconstruction. Between 2015 and 2017, PMRT was delivered to 46 consecutive patients (median age 50 years) with expander reconstruction. Median follow-up was 27 months (range 10-41). Two patients (4.3%) had a reconstruction failure, as expander rupture and infection, following the first- and the second-stage reconstruction, respectively. In most cases expanders were completely inflated before PMRT (65.2%). Median expander volume before PMRT was 425 cm3 (range 150-700 cm3). The amount of expander inflation did not significantly affect dosimetry, except for skin dose, with a surface receiving more than 30 Gy of 36.6 ± 0.9 cm2 and 47.0 ± 2.5 cm2 for a volume expander below or above the median, respectively. However, this variable was not predictor for complications. Disease progression was recorded in 15.2% of patients. PMRT using VMAT technique for breast cancer patients with expander reconstruction is associated with a very low complication rate. The expander volume before PMRT does not significantly compromise radiotherapy dose distribution.

Entities:  

Keywords:  Autologous fat grafting; Immediate breast reconstruction; Postmastectomy radiotherapy; Tissue expander; VMAT

Mesh:

Year:  2019        PMID: 31028487     DOI: 10.1007/s12032-019-1275-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  4 in total

1.  Comment on: "Oral and Maxillofacial Autologous Fat Transplantation: History, Clinical Application Status and Research Progress".

Authors:  Andrea Battistini; Maria Angela Romeo; Valeria Bandi; Fabio Caviggioli; Valeriano Vinci
Journal:  Aesthetic Plast Surg       Date:  2021-04-26       Impact factor: 2.326

Review 2.  Recent advances in radiotherapy of breast cancer.

Authors:  Jan Haussmann; Stefanie Corradini; Carolin Nestle-Kraemling; Edwin Bölke; Freddy Joel Djiepmo Njanang; Bálint Tamaskovics; Klaus Orth; Eugen Ruckhaeberle; Tanja Fehm; Svjetlana Mohrmann; Ioannis Simiantonakis; Wilfried Budach; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2020-03-30       Impact factor: 3.481

Review 3.  Breast Radiotherapy after Oncoplastic Surgery-A Multidisciplinary Approach.

Authors:  Gabrielle Metz; Kylie Snook; Samriti Sood; Sally Baron-Hay; Andrew Spillane; Gillian Lamoury; Susan Carroll
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

4.  A Retrospective Dosimetric Analysis of the New ESTRO-ACROP Target Volume Delineation Guidelines for Postmastectomy Volumetric Modulated Arc Therapy After Implant-Based Immediate Breast Reconstruction.

Authors:  Kyung Hwan Chang; Jee Suk Chang; Kwangwoo Park; Seung Yeun Chung; Se Young Kim; Ryeong Hwang Park; Min Cheol Han; Jihun Kim; Hojin Kim; Ho Lee; Dong Wook Kim; Yong Bae Kim; Jin Sung Kim; Chae-Seon Hong
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.